Volume 15, Issue 10, Pages (June 2016)

Slides:



Advertisements
Similar presentations
Volume 23, Issue 2, Pages (April 2018)
Advertisements

Volume 16, Issue 5, Pages (August 2016)
Volume 15, Issue 3, Pages (April 2016)
Volume 17, Issue 12, Pages (December 2016)
Volume 11, Issue 11, Pages (June 2015)
Volume 38, Issue 4, Pages (May 2010)
Marios Agelopoulos, Daniel J. McKay, Richard S. Mann  Cell Reports 
Volume 18, Issue 12, Pages (March 2017)
Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency- Associated Genes  Steven Blinka, Michael H. Reimer, Kirthi Pulakanti,
Volume 44, Issue 3, Pages (November 2011)
Volume 23, Issue 7, Pages (May 2018)
Volume 7, Issue 1, Pages (July 2010)
Volume 16, Issue 6, Pages (June 2002)
Volume 28, Issue 1, Pages (January 2014)
Lucas J.T. Kaaij, Robin H. van der Weide, René F. Ketting, Elzo de Wit 
Formation of Chromosomal Domains by Loop Extrusion
Volume 23, Issue 5, Pages (May 2018)
Adrien Le Thomas, Georgi K. Marinov, Alexei A. Aravin  Cell Reports 
Volume 17, Issue 4, Pages (October 2015)
Volume 20, Issue 6, Pages (August 2017)
Volume 13, Issue 8, Pages (November 2015)
Volume 28, Issue 3, Pages (March 2008)
Volume 10, Issue 8, Pages (March 2015)
Volume 48, Issue 5, Pages (December 2012)
Volume 49, Issue 1, Pages (January 2013)
Volume 16, Issue 8, Pages (August 2016)
Volume 7, Issue 9, Pages (September 2014)
Figure 2. Ectopic expression of PLZF modulates H3K27ac at enhancer regions in myeloid cells. (A) Box plots showing ... Figure 2. Ectopic expression of.
Volume 63, Issue 4, Pages (August 2016)
Volume 17, Issue 6, Pages (November 2016)
Volume 16, Issue 3, Pages (March 2015)
Volume 13, Issue 1, Pages (July 2013)
Volume 34, Issue 3, Pages (March 2011)
Volume 13, Issue 12, Pages (December 2015)
Volume 47, Issue 6, Pages (September 2012)
Volume 67, Issue 6, Pages e6 (September 2017)
Volume 10, Issue 7, Pages (February 2015)
Wei Jiang, Yuting Liu, Rui Liu, Kun Zhang, Yi Zhang  Cell Reports 
Volume 22, Issue 10, Pages (March 2018)
Volume 10, Issue 3, Pages (March 2018)
Volume 44, Issue 3, Pages (November 2011)
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
Volume 25, Issue 13, Pages e5 (December 2018)
Volume 72, Issue 2, Pages e5 (October 2018)
Evolution of Alu Elements toward Enhancers
Volume 14, Issue 6, Pages (June 2014)
Histone Modifications Associated with Somatic Hypermutation
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains  Lindsay Romo, Ami Ashar-Patel, Edith.
Volume 14, Issue 5, Pages (February 2016)
Volume 11, Issue 11, Pages (June 2015)
Volume 35, Issue 2, Pages (August 2011)
Volume 16, Issue 1, Pages (June 2016)
Volume 20, Issue 7, Pages (August 2017)
Volume 14, Issue 6, Pages (June 2014)
Volume 27, Issue 5, Pages (November 2007)
Volume 27, Issue 5, Pages (November 2007)
Volume 63, Issue 3, Pages (August 2016)
Volume 9, Issue 3, Pages (November 2014)
Volume 27, Issue 5, Pages (September 2007)
Volume 56, Issue 6, Pages (December 2014)
Volume 22, Issue 2, Pages (April 2006)
Fig. 3 Conserved genomic association of PRC1 activity in different leukemic cells. Conserved genomic association of PRC1 activity in different leukemic.
Volume 64, Issue 5, Pages (December 2016)
Volume 9, Issue 3, Pages (November 2014)
Volume 19, Issue 10, Pages (June 2017)
Regulation of TCRβ Gene Assembly by a Promoter/Enhancer Holocomplex
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Volume 14, Issue 6, Pages (February 2016)
Mutant TERT promoter displays active histone marks and distinct long-range interactions: A, cell lines that were used in the study with their origin and.
Presentation transcript:

Volume 15, Issue 10, Pages 2159-2169 (June 2016) Active and Inactive Enhancers Cooperate to Exert Localized and Long-Range Control of Gene Regulation  Charlotte Proudhon, Valentina Snetkova, Ramya Raviram, Camille Lobry, Sana Badri, Tingting Jiang, Bingtao Hao, Thomas Trimarchi, Yuval Kluger, Iannis Aifantis, Richard Bonneau, Jane A. Skok  Cell Reports  Volume 15, Issue 10, Pages 2159-2169 (June 2016) DOI: 10.1016/j.celrep.2016.04.087 Copyright © 2016 The Author(s) Terms and Conditions

Cell Reports 2016 15, 2159-2169DOI: (10.1016/j.celrep.2016.04.087) Copyright © 2016 The Author(s) Terms and Conditions

Figure 1 Enhancer Hubs and Their Impact on Super-Enhancer Activity (A) Top: scheme showing the location of the Igk AgR locus with its respective enhancers: MiEκ, 3′Eκ, and Edκ on murine chromosome 6. Bottom: outline of the different stages of B cell development. Stages under investigation are highlighted in orange (pre-B and immature B). (B) Left: distribution of H3K27Ac signal across the peaks identified by MACS in pre-B and immature B cells with super-enhancers containing an exceptionally high amount of H3K27Ac. Right: H3K27Ac signal at the 3′ end of Igk in pre-B and immature B cells with the region defined as the super-enhancer highlighted. ATAC-seq profiles of the region in wild-type pre-B cells. (C) Detailed scheme showing the location of MiEκ and 3′Eκ 4C baits. (D) 4C signal normalized by DESeq2 in 5 kb windows sliding by 0.5 kb for ∼50 kb region neighboring the MiEκ and 3′Eκ baits in WT versus enhancer-deficient cells. Filled circles highlight significant differences in 4C-seq counts identified by DESeq2 analysis of the plotted region. Transcriptional output within the region is represented below each plot by RNA-seq profiles. (E) Model showing the organization of the individual enhancer elements within the Igk super-enhancer in wild-type versus MiEκ−/− and 3′Eκ−/− pre-B cells. See also Figure S1 and Tables S1 and S2. Cell Reports 2016 15, 2159-2169DOI: (10.1016/j.celrep.2016.04.087) Copyright © 2016 The Author(s) Terms and Conditions

Figure 2 The MiEκ Regulates T Cell Development and Tcrb Rearrangement (A) Outline of the different stages of T cell development. Stages under investigation are highlighted in blue (DN2/3 and DP). (B) DNA-FISH combined with immunofluorescence to detect γH2AX-containing repair foci at the Igk and Tcrb loci. Bar graphs represent three independent experiments. Error bars reflect SEM. Examples of confocal sections are shown in the panels below. (C) Germline retention assay, performed on genomic DNA, to assess the proportion of Tcrb loci in germline versus rearranged conformation. The scheme shows the primer design. Plots showing the percentage of retention in wild-type and MiEκ−/− DN2/3 cells normalized by analysis of RAG1-deficient control cells (a combination of two independent repeats of two wild-type versus two MiEκ−/− samples). (D) Left: FACS analysis of DN cell development in thymi isolated from wild-type and MiEκ−deficient mice. Right: bar plots show quantification of differences in the absolute numbers of wild-type versus MiEκ−/− DN cells per thymus from a combination of three independent experiments. Cells were gated on Thy1.2+TCRbloCD4−CD8− and the DN population defined by expression of CD44 and CD25 as followed: DN1 CD44+CD25−, DN2 CD44+CD25+, DN3 CD44−CD25+ and DN4 CD44−CD25−. Error bars represent SEM. See also Figure S2 and Tables S1 and S2. Cell Reports 2016 15, 2159-2169DOI: (10.1016/j.celrep.2016.04.087) Copyright © 2016 The Author(s) Terms and Conditions

Figure 3 The Presence of Jκ-Cκ Transcripts in Igk Is Linked to a Long-Range Contact with Tcrb (A) RNA-seq, ATAC-seq, and iChIP for H3K27Ac reveal the activity of the 3′ Igk interacting domain. ncRNA track displays transcripts identified by transcriptome assembly using cufflinks V2.2.1 (see the Experimental Procedures for more details). The bottom track shows the 3′ Igk interacting domain called by 4C-ker from the Eβ viewpoint. (B) Detailed scheme showing the location of the Eβ 4C bait relative to the enhancer. (C) Interaction profile of Eβ for the 6 Mb region encompassing Igk in wild-type DN, DP, pre-B, and immature B cells using 4C counts in 200 kb windows sliding by 20 kb. (D) Interaction profile of Eβ with the 3′ Igk interacting domain in WT versus Eβ and MiEκ-deficient DN cells using 50 kb windows sliding by 5 kb. A purple bar delineates a 200 kb window, which chromosome-wide DESeq2 analysis identified as having a significantly different 4C signal in Eβ−/− versus wild-type DN cells. A t test was performed on 4C counts to assess the same 200 kb window for differences between wild-type versus MiEκ−/− (gold bar). See also Figures S3 and S4 and Tables S1 and S2. Cell Reports 2016 15, 2159-2169DOI: (10.1016/j.celrep.2016.04.087) Copyright © 2016 The Author(s) Terms and Conditions

Figure 4 The MiEκ Regulates CBFβ Binding at Eβ in DN Cells (A) CBFβ ChIP-qPCR for REIR plotted as fold enrichment over negative control. (B) CBFβ ChIP-qPCR for Eβ plotted as fold enrichment over negative control. A t test was performed to determine significance of fold enrichment change at Eβ in EβRUNX (RUNX binding sites at Eβ mutated, p = 0.004398) and in MiEκ−/− (p = 0.005621) DN cells. Error bars represent SEM of three experiments. (C) Model implicating the CBFβ-bound REIR and MiEκ in cooperatively regulating transcription factor binding at Eβ. In wild-type T and B cells, Eβ and MiEκ, respectively, regulate rearrangement of Tcrb and Igk. The three enhancers of Igk (MiEκ, 3′Eκ, and Edκ) comprise the super-enhancer in developing B cells with individual enhancers interacting and cooperatively regulating transcriptional output. In wild-type DN cells, Jκ-Cκ transcripts are expressed at the 3′ end of Igk. The contact between Eβ and the 3′ Igk interacting domain encompassing CBFβ-bound REIR promotes Tcrb recombination in an Eβ- and MiEκ-dependent manner. An absence of MiEκ leads to a reduction in the contact and transcription at the 3′ end of Igk, which in turn leads to a reduction in the localized concentration of CBFβ and RUNX1 in the proximity of Eβ, thereby impairing its function. See also Tables S1 and S2. Cell Reports 2016 15, 2159-2169DOI: (10.1016/j.celrep.2016.04.087) Copyright © 2016 The Author(s) Terms and Conditions